Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zanolimumab + CHOP in CD4+ Non-cutaneous Peripheral T-cell Lymphoma
NCT00893516Phase 2Terminated
- Sponsor
- Emergent BioSolutions
- Start
- May 2007
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of zanolimumab in peripheral T-cell lymphoma (PTCL), sponsored by Emergent BioSolutions. Started May 2007; status: terminated.
02
Drugs
zanolimumab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00893516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893516.